Log in
Enquire now
‌

US Patent 12060585 Expression of novel cell tags

Patent 12060585 was granted and assigned to Precigen on August, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Precigen
Precigen
0
Date Filed
May 5, 2021
0
Date of Patent
August 13, 2024
0
Patent Applicant
Precigen
Precigen
0
Patent Application Number
17302514
0
Patent Citations
‌
US Patent 7067318 Methods for transfecting T cells
0
‌
US Patent 7091038 Ecdysone receptor-based inducible gene expression system
0
‌
US Patent 7144575 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 7148203 Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
0
‌
US Patent 7172869 Methods for transfecting T cells
0
‌
US Patent 7175843 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 7232566 Methods for treating HIV infected subjects
0
‌
US Patent 7531326 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system
0
‌
US Patent 7563879 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
0
‌
US Patent 7601508 Whitefly ecdysone receptor polypeptide and methods
0
•••
Patent Inventor Names
Rutul Shah
0
Ramya Yarlagadda
0
Peter Emtage
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12060585
0
Patent Primary Examiner
‌
Ruixiang Li
0

Find more entities like US Patent 12060585 Expression of novel cell tags

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.